Skip to main content

Acute and Chronic Graft-Versus-Host Disease of the Skin

  • Chapter
  • First Online:
Book cover Case-Based Inpatient Pediatric Dermatology

Abstract

Graft-versus-host disease (GVHD) is one of the most challenging diseases to diagnose and manage in both children and adults. Despite significant research and advances, GVHD remains a significant cause of morbidity and mortality in the post-hematopoietic stem cell transplant population. Given that skin is the most common organ affected in both acute and chronic forms of GVHD, it is imperative for dermatologists not only to recognize cutaneous manifestations but also to familiarize themselves with first-line therapies for these conditions. In this chapter, we describe four unique cases of acute and chronic GVHD, and discuss the differential diagnosis, diagnostic pearls, and therapeutic approach to these diseases. We begin with a case of classic acute GVHD, and review characteristic clinical features, risk factors, differential diagnosis, and first-line therapies. We then move on to a rare case of toxic epidermal necrolysis-like acute GVHD and discuss second- and third-line agents for treatment-refractory disease, including interventions that saved the patient’s life. In case 3, we transition to a discussion of chronic GVHD, and present a patient with sclerotic disease, reviewing clinical features, risk factors, and first-line therapies for this condition. Lastly, we conclude our chapter with a discussion of an atypical nonsclerotic form cutaneous chronic GVHD associated with a good prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jacobsohn DA. Acute graft-versus-host disease in children. Bone Marrow Transplant. 2008;41(2):215–21.

    Article  CAS  PubMed  Google Scholar 

  2. Eisner MD, August CS. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone Marrow Transplant. 1995;15(5):663–8.

    CAS  PubMed  Google Scholar 

  3. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–56.

    Article  PubMed  Google Scholar 

  4. Hymes SR, Alousi AM, Cowen EW. Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease. J Am Acad Dermatol. 2012;66(4):535.e1–16.

    Article  Google Scholar 

  5. Dignan FL, Clark A, Amrolia P, et al. Diagnosis and management of acute graft-versus-host disease. Br J Haematol. 2012;158(1):30–45.

    Article  CAS  PubMed  Google Scholar 

  6. Hu SW, Cotliar J. Acute graft-versus-host disease following hematopoietic stem-cell transplantation. Dermatol Ther. 2011;24(4):411–23.

    Article  PubMed  Google Scholar 

  7. Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol. 2006;142(2):175–82.

    Article  PubMed  Google Scholar 

  8. Kuykendall TD, Smoller BR. Lack of specificity in skin biopsy specimens to assess for acute graft-versus-host disease in initial 3 weeks after bone-marrow transplantation. J Am Acad Dermatol. 2003;49(6):1081–5.

    Article  PubMed  Google Scholar 

  9. Zhou Y, Barnett MJ, Rivers JK. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation. Arch Dermatol. 2000;136(6):717–21.

    Article  CAS  PubMed  Google Scholar 

  10. Byun HJ, Yang JI, Kim BK, Cho KH. Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions. J Am Acad Dermatol. 2011;65(4):726–32.

    Article  PubMed  Google Scholar 

  11. Frankel HC, Qureshi AA. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Am J Clin Dermatol. 2012;13(2):113–23.

    Article  PubMed  Google Scholar 

  12. Olson KA, West K, Mccarthy PL. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. Pharmacotherapy. 2014;34(6):e60–4.

    Article  CAS  PubMed  Google Scholar 

  13. Gratwohl A, Hermans J, Apperley J, et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. Blood. 1995;86(2):813–8.

    CAS  PubMed  Google Scholar 

  14. Baird K, Cooke K, Schultz KR. Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am. 2010;57(1):297–322.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97(4):855–64.

    Article  CAS  PubMed  Google Scholar 

  16. Goiriz R, Peñas P, Pérez-gala S, et al. Stage IV cutaneous acute graft-versus-host disease. Clinical and histological study of 15 cases. J Eur Acad Dermatol Venereol. 2009;23(12):1398–404.

    Article  CAS  PubMed  Google Scholar 

  17. Irvine AD, Hoeger PH, Yan AC. Harper’s textbook of pediatric dermatology. West Sussex: Wiley-Blackwell; 2011.

    Book  Google Scholar 

  18. Calore E, Marson P, Pillon M, et al. Treatment of acute graft-versus-host disease in childhood with extracorporeal photochemotherapy/photopheresis: the Padova experience. Biol Blood Marrow Transplant. 2015;21(11):1963–72.

    Article  PubMed  Google Scholar 

  19. Couriel D, Hosing C, Saliba R, et al. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work? Biol Blood Marrow Transplant. 2006;12(1 Suppl 2):37–40.

    Article  PubMed  Google Scholar 

  20. Abu-dalle I, Reljic T, Nishihori T, et al. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies. Biol Blood Marrow Transplant. 2014;20(11):1677–86.

    Article  PubMed  Google Scholar 

  21. Hymes SR, Alousi AM, Cowen EW. Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease. J Am Acad Dermatol. 2012;66(4):515.e1–18.

    Article  Google Scholar 

  22. Holtick U, Albrecht M, Chemnitz JM, et al. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev. 2014;4:CD010189.

    Google Scholar 

  23. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342(25):1846–54.

    Article  CAS  PubMed  Google Scholar 

  24. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet. 1995;346(8969):214–9.

    Article  CAS  PubMed  Google Scholar 

  25. Jagasia MH, Greinix HT, Arora M, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389–401.e1.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Patel AR, Pavletic SZ, Turner ML, Cowen EW. The isomorphic response in morphea-like chronic graft-vs-host disease. Arch Dermatol. 2008;144(9):1229–31.

    PubMed  PubMed Central  Google Scholar 

  27. Arora M. Therapy of chronic graft-versus-host disease. Best Pract Res Clin Haematol. 2008;21(2):271–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wolff D, Schleuning M, Von harsdorf S, et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17(1):1–17.

    Article  PubMed  Google Scholar 

  29. Connolly KL, Griffith JL, Mcevoy M, Lim HW. Ultraviolet A1 phototherapy beyond morphea: experience in 83 patients. Photodermatol Photoimmunol Photomed. 2015;31(6):289–95.

    Article  PubMed  Google Scholar 

  30. Enk CD, Elad S, Vexler A, Kapelushnik J, Gorodetsky R, Kirschbaum M. Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplant. 1998;22(12):1179–83.

    Article  CAS  PubMed  Google Scholar 

  31. Brazzelli V, Grasso V, Muzio F, et al. Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients. Br J Dermatol. 2010;162(2):404–9.

    Article  CAS  PubMed  Google Scholar 

  32. Apisarnthanarax N, Donato M, Körbling M, et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant. 2003;31(6):459–65.

    Article  CAS  PubMed  Google Scholar 

  33. Foss FM, Divenuti GM, Chin K, et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant. 2005;35(12):1187–93.

    Article  CAS  PubMed  Google Scholar 

  34. Greinix HT, Volc-platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998;92(9):3098–104.

    CAS  PubMed  Google Scholar 

  35. Kennedy-nasser AA, Ku S, Castillo-caro P, et al. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity. Clin Cancer Res. 2014;20(8):2215–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Koreth J, Matsuoka K, Kim HT, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365(22):2055–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Chakrabarti S, MacDonald D, Hale G, Holder K, Turner V, Czarnecka H, Thompson J, Fegan C, Waldmann H, Milligan DW. T-cell depletion with Campath-1H “in the bag” for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival. Br J Haematol. 2003;121:109–18.

    Article  PubMed  Google Scholar 

  38. Chosidow O, Bagot M, Vernant JP, Roujeau JC, Cordonnier C, Kuentz M, et al. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol. 1992;26:49–55.

    Article  CAS  PubMed  Google Scholar 

  39. Skert C, Patriarca F, Sperotto A, Cerno M, Fili C, Zaja F, et al. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica. 2006;91:258–61.

    PubMed  Google Scholar 

  40. Kim SJ, Choi JM, Kim JE, Cho BK, Kim DW, Park HJ. Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases: a retrospective study in Korean patients. Int J Dermatol. 2010;49(12):1386–92.

    Article  PubMed  Google Scholar 

  41. Huang JT, Duncan CN, Boyer D, Khosravi H, Lehmann LE, Saavedra A. Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children. Bone Marrow Transplant. 2014;49(12):1521–7.

    Article  CAS  PubMed  Google Scholar 

  42. Creamer D, Martyn-simmons CL, Osborne G, et al. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Arch Dermatol. 2007;143(9):1157–62.

    Article  PubMed  Google Scholar 

  43. Shulman HM, Cardona DM, Greenson JK, et al. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015;21(4):589–603.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer T. Huang MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Khosravi, H., Mikailov, A., Huang, J.T. (2016). Acute and Chronic Graft-Versus-Host Disease of the Skin. In: Hogeling, M. (eds) Case-Based Inpatient Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31569-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31569-0_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31567-6

  • Online ISBN: 978-3-319-31569-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics